Form 4: Conmed Corp Executive Stephan Epinette Reports RSU Settlement

Stephan Epinette, VP GM International at Conmed Corp, reports the settlement of vested restricted stock units (RSUs) resulting in the delivery of common stock shares.

Summary

• Stephan Epinette, a VP GM International at Conmed Corp, filed a Form 4 on May 13, 2025, reporting a transaction on March 3, 2025.
• The transaction involved the settlement of vested restricted stock units (RSUs), resulting in the acquisition of 17,144 shares of common stock.
• These shares were acquired upon the vesting of RSUs, with a corresponding decrease in the number of RSUs held.
• The RSUs vest over a four-year period, with zero shares vesting in 2026, 8,572 shares vesting on March 3, 2027, 6,429 shares vesting on March 3, 2028, and 2,143 shares vesting on March 3, 2029.
• Following the transaction, Epinette directly owns 17,144 shares of Conmed Corp common stock.

Sentiment

Score: 5

Explanation: Neutral sentiment as it's a routine disclosure of an insider transaction related to equity compensation.

Positives

• The vesting of RSUs indicates that performance milestones were likely met, which is a positive signal.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates the vesting of previously granted equity compensation.

Stakeholder Impact

• The transaction has a minor impact on shareholders as it reflects the planned dilution from equity compensation.

Key Dates

Keywords

Form 4, CONMED Corp, Stephan Epinette, RSU, Restricted Stock Units, Beneficial Ownership, Insider Trading